BMAC – Biopharmaceutical Manufacturer's Advisory Council
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
Share Share on facebook Share on twitter Share on linkedin Share on email The tropical climate conditions pose an important challenge for pharmaceutical manufacturing facilities based in Singapore that rely on chiller plant to provide ideal temperature and humidity conditions in clean rooms. As a result, the chiller plant is constantly in operation and subjected
Share Share on facebook Share on twitter Share on linkedin Share on email Although Singapore accounts for around 0.11 percent of global carbon emissions, the country is committed to reduce emissions intensity by 36 per cent below 2005 levels by 2030 and stabilise emissions with the aim of peaking around 2030. At BMAC, we are